REVIVA PHARMACEUTICALS HOLDI (RVPH) Stock Income Statement
NASDAQ:RVPH • US76152G1004
Current stock price
0.7416 USD
-0.04 (-5.38%)
At close:
0.7267 USD
-0.01 (-2.01%)
After Hours:
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 22.93M | 30.80M | 39.50M | 28.23M | 10.10M | |||
| Research and Development | 14.65M | 22.91M | 31.42M | 22.87M | 4.85M | |||
| Selling, General, and Administrative Expenses | 8.27M | 7.89M | 8.08M | 5.36M | 5.25M | |||
| Operating Income | -22.93M | -30.80M | -39.50M | -28.23M | -10.10M | |||
| Interest Income/Expense | 191.80K | 342.90K | 499.00K | 182.80K | -2.40K | |||
| Other Income/Expense | -2.00K | 556.70K | -239.20K | -194.70K | 1.59M | |||
| Income Before Taxes | -22.74M | -29.90M | -39.24M | -28.24M | -8.52M | |||
| Income Tax | 20.70K | 19.50K | 16.90K | 20.80K | 6.00K | |||
| Net Income | -22.76M | -29.92M | -39.26M | -28.26M | -8.52M | |||
| EBITDA | N/A | N/A | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -9.44 | -18.05 | -32.99 | -28.96 | -11.52 | |||
| Non GAAP EPS | -9.20 | -18.20 | -32.80 | -25.00 | -0.56 | |||
| Statistics | ||||||||
All data in USD